查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924699

医用胃造瘻管市场按材质、适应症、病患年龄、最终用户和通路划分－2026-2032年全球预测

Medical Gastrostomy Tube Market by Tube Material, Indication, Patient Age, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用胃造瘻管市场价值将达到 11.1 亿美元，到 2026 年将成长至 12.1 亿美元，到 2032 年将达到 21.9 亿美元，年复合成长率为 10.22%。

关键市场统计数据
基准年 2025 11.1亿美元
预计年份：2026年 12.1亿美元
预测年份 2032 21.9亿美元
复合年增长率 (%) 10.22%

阐明胃造瘻管在医疗保健环境中的临床重要性和不断变化的作用，同时强调其操作性和以病人为中心的重要性。

胃造瘻管是经肠营养和药物输注的重要途径，适用于无法充分经口摄取或吸收营养的患者。这些装置种类繁多，从传统的外置管到旨在最大限度减少社会歧视并方便患者日常生活的低调内置系统，应有尽有。随着临床实践向门诊和居家照护的转变，胃造瘻管的应用范围也从急性医院扩展到慢性神经系统疾病（可损害吞嚥和消化功能）、肿瘤支持治疗以及复杂遗传性疾病的长期管理等领域。

产品创新、医疗服务分散化、全通路分销和监管如何共同重塑胃造瘻管护理的策略和病患体验

胃造瘻管领域正经历变革时期，这场变革的驱动力来自技术进步、医疗服务分散化以及以使用者为中心的设计理念。低轮廓装置和固定机制的创新提高了舒适度，减少了患者的耻辱感，从而提高了门诊患者及其看护者的接受度。材料的进步，例如聚氨酯和硅胶配方的改进，逐步提升了生物相容性和耐用性，从而减少了更换频率和装置相关併发症。

了解2025年关税变化对医疗设备供应链的采购、製造韧性、采购合约和监管协调的影响

2025年美国关税调整对医疗设备製造商及其商业伙伴的供应链、筹资策略和成本管理产生了实际的影响。关税导致进口零件和成品到岸成本增加，迫使各企业重新评估其筹资策略，许多企业开始寻求近岸製造、多源采购策略或垂直整合的供应链结构，以降低波动风险。这些策略转变直接影响采购计画、生产升级的资金分配以及无菌生产能力的地理分布。

详细的细分洞察揭示了设备类型、临床环境、通路、临床适应症、年龄层和材料选择如何决定产品类型、适用性和服务需求。

对产品和商业性细分市场的分析揭示了不同设备类型、临床环境和患者群体在应用和服务需求方面的差异。传统导管和Low profile导管之间的产品类型细分定义了核心应用场景。传统导管配置包括球囊和球顶固定机制的各种变体，每种变体都会影响留置技术、维护程序和併发症。同时，Low profile导管涵盖球囊和水充气固定方式，优先考虑低可见度和患者舒适度。最终用户细分突显了门诊手术中心、居家医疗、医院和专科诊所之间在营运和支援需求方面的差异。在居家医疗领域，专科护理和自我管理应用场景需要不同的培训计划和耗材商品搭售。医院又细分为综合医院和专科医院，这两者在采购规模和临床手术量方面有差异。

区域法规结构、医疗服务模式和分销基础设施将如何影响美洲、欧洲、中东和非洲以及亚太地区的临床应用和商业策略

区域趋势正在影响主要地理区域的胃造瘻管护理临床实践模式、监管重点和商业管道。美洲拥有多元化的医疗保健系统，涵盖大规模综合医院网络和广泛的居家医疗生态系统。这种多样性推动了对机构级传统胃造瘻管和病患友善型、低调系统的强劲需求，同时注重高效的采购流程和上市后的临床支援。该地区的临床指南和支付方框架强调结果追踪和成本效益，鼓励相关人员将器材选择与更广泛的基于价值的医疗保健倡议相结合。

竞争和策略趋势强调临床证据、整合服务交付、供应链韧性和数位化参与，以实现永续优势。

胃造瘻管领域的竞争格局已不再仅由价格驱动，而是更重视产品差异化、服务整合与实证实践。领先的製造商和创新新兴企业正积极投资临床研究，以证明其产品能够减少器械相关併发症、提高患者生活品质并简化看护者的工作流程。策略性措施包括拓展产品线，涵盖传统型和小型化胃造瘻管；创建将器械供应、临床医生培训和病患教育相结合的服务包；以及与居家医疗机构和专科诊所合作，确保提供端到端的护理路径。

製造商和医疗保健领导者可采取的切实可行的策略重点，以提高产品易用性、证据产生、分销范围和供应链韧性。

产业领导者应优先采取一系列切实可行的行动，将洞察转化为临床应用、供应链韧性和商业性绩效等方面的可衡量成果。首先，产品开发蓝图应与看护者的易用性和居家照护需求保持一致，推动对低调设计和可减少维护并提高患者舒适度的固定机制的投资。同时，探索可简化灭菌和生产流程且维持临床性能的材料创新，从而支持供应链的柔软性。

一种透明的多来源调查方法，结合了临床医生参与、监管审查、采购实践分析以及严格的结果交叉检验。

本分析的调查方法结合了结构化的原始研究（包括与领域专家的访谈）、对同行评审临床文献的系统性回顾，以及对医疗服务机构中观察到的采购和分销实践模式的三角验证。原始数据包括对临床医生、供应链经理、居家医疗协调员和医疗设备技术人员的访谈，旨在了解实际环境中设备性能的操作细节和注意事项。次要资料包括设备标籤资讯、监管申报文件、来自临床註册机构的公开资料以及程序最佳实践指南，以检验临床和安全性特征。

本文简要概述了决定管饲护理长期应用和价值创造的关键医疗设备、临床、商业和营运问题。

总而言之，胃造瘻管市场格局正受到多种因素的共同影响而重塑：旨在提升病患舒适度和便于居家管理的创新产品、强调门诊和居家照护的医疗服务模式转变、机构和消费者通路分销的多元化，以及推动供应链重组的宏观经济压力。这些趋势共同促使製造商、医疗服务提供者和采购团队采取整合策略，将设备设计、实证实践、服务提供和营运韧性视为相互依存的优先事项。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依材质的医用胃造瘻管市场

  • 聚氨酯
  • 硅酮

9. 依适应症分類的医用胃造瘻管市场

  • 癌症
  • 胃肠道营养障碍
  • 遗传性疾病
  • 神经系统疾病

第十章 依病人年龄分類的医用胃造瘻管市场

  • 成人版
  • 老年人
  • 儿童

第十一章 依最终使用者分類的医用胃造瘻管市场

  • 门诊手术中心
  • 居家照护
    • 专科护理
    • 自我管理
  • 医院
    • 综合医院
    • 专科医院
  • 专科诊所

第十二章 按分销管道分類的医用胃造瘻管市场

  • 离线
  • 在线的
    • 製造商官方网站
    • 电子商务平台

第十三章 各地区医用胃造瘻管市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医疗胃造瘻管市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国医用胃造瘻管市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医用胃造瘻管市场

第十七章：中国医用胃造瘻管市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Applied Medical Technology, Inc.
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • ConMed Corporation
  • Cook Medical LLC
  • Danone SA
  • Degania Medical Devices Ltd.
  • Fresenius SE & Co. KGaA
  • Global Medikit Limited
  • GST Corporation Limited
  • Halyard Health, Inc.
  • Integra LifeSciences Holdings Corporation
  • Medicina Ltd.
  • Medtronic plc
  • Poly Medicure Limited
  • Romsons International
  • Teleflex Incorporated
  • Vygon SA
Product Code: MRR-7A380DA7C436

The Medical Gastrostomy Tube Market was valued at USD 1.11 billion in 2025 and is projected to grow to USD 1.21 billion in 2026, with a CAGR of 10.22%, reaching USD 2.19 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.11 billion
Estimated Year [2026] USD 1.21 billion
Forecast Year [2032] USD 2.19 billion
CAGR (%) 10.22%

Defining the clinical importance and evolving role of gastrostomy tubes across care settings while highlighting operational and patient-centered imperatives

Gastrostomy tubes serve as essential conduits for enteral nutrition and therapeutic administration in patients who cannot adequately ingest or absorb nutrients orally. These devices span a spectrum from traditional external tubes to low-profile internal systems designed to minimize stigma and facilitate daily living. As clinical practice shifts toward ambulatory and home-based care, the role of gastrostomy devices has expanded beyond acute hospital settings into long-term management of chronic neurological conditions, oncologic support, and complex genetic disorders that impair swallowing or digestion.

Clinical decision-making increasingly balances device selection with patient lifestyle, caregiver capability, and reimbursement parameters. Advances in material science and retention mechanisms have created options that reduce complications such as leakage, dislodgement, and local infection. At the same time, rising emphasis on patient-centered care and shorter inpatient stays places pressure on manufacturers and care providers to deliver safer, easier-to-manage products and comprehensive caregiver training.

In parallel, supply chain and distribution dynamics are reshaping how devices reach end users, with direct hospital procurement, online channels, and retail pharmacies each demanding different packaging, documentation, and service models. Stakeholders must therefore coordinate across clinical, commercial, and regulatory domains to ensure consistent standards of care while responding to evolving payer expectations and operational realities.

How product innovation, decentralizing care, omnichannel distribution, and regulatory scrutiny are jointly redefining strategy and patient experience in gastrostomy care

The gastrostomy tube landscape is undergoing a period of transformative change driven by technological refinement, care delivery decentralization, and user-centric design priorities. Low-profile devices and innovations in retention mechanisms have improved comfort and reduced stigma, enabling broader acceptance among ambulatory patients and caregivers. Material advances such as refined polyurethane and silicone formulations have incrementally enhanced biocompatibility and resilience, which in turn reduce replacement frequency and device-related complications.

Concurrently, care delivery is shifting away from prolonged hospitalization toward home-based management and ambulatory procedural settings, raising the importance of product ease-of-use and a seamless post-procedural support infrastructure. Telehealth and remote monitoring solutions are beginning to intersect with device management, enabling clinicians to extend follow-up and troubleshooting into the home environment and to triage issues before they escalate.

Commercially, distribution models are diversifying as manufacturers and suppliers adapt to omnichannel expectations; direct tender and hospital supply integrations remain central for institutional customers, while online sales and retail pharmacy access are expanding reach into home care markets. Regulatory emphasis on patient safety and post-market surveillance has encouraged manufacturers to invest in clinical evidence and training programs, and reimbursement bodies are increasingly scrutinizing total cost of care rather than unit price alone. These interconnected shifts are collectively raising the bar for product differentiation and service-led value propositions.

Understanding how 2025 tariff changes have reshaped sourcing, manufacturing resilience, procurement contracts, and regulatory coordination in medical device supply chains

United States tariff adjustments in 2025 have introduced tangible ripple effects across supply chains, procurement strategies, and cost management for medical device manufacturers and their commercial partners. Tariff-driven increases in the landed cost of imported components and finished devices have prompted organizations to re-evaluate sourcing strategies, with many pursuing nearer-shore manufacturing, multi-sourcing, or vertically integrated supply arrangements to mitigate volatility. These strategic shifts have direct implications for procurement timelines, capital allocation for manufacturing upgrades, and the geographic footprint of sterile production capacity.

Procurement teams and hospital supply chains are responding by recalibrating inventory policies and contract structures to maintain continuity of care while protecting margin. In some instances, longer lead times and higher input costs have accelerated collaboration between manufacturers and large institutional buyers to develop fixed-price or hedged contract mechanisms that stabilize unit costs without compromising supply reliability. Manufacturers prioritizing tariff sensitivity have intensified focus on design for manufacturability and material substitution where clinically appropriate, seeking to preserve clinical performance while optimizing component cost and regulatory compliance.

Regulatory and quality teams face increased complexity as production shifts or material changes necessitate supplementary validation and documentation. Consequently, cross-functional coordination between commercial, regulatory, and supply chain teams has become essential to manage product introductions and lifecycle changes. Overall, the tariff environment has acted as a catalyst for structural resilience planning, encouraging investments in flexible manufacturing, supplier diversification, and contractual frameworks that align clinical continuity with economic stability.

Detailed segmentation-driven insights revealing how device type, care setting, distribution routes, clinical indication, age groups, and material choices determine product fit and service needs

Analysis of the product and commercial segmentation landscape reveals differentiated adoption and service requirements across device types, care settings, and patient populations. Product Type distinctions between Conventional Tube and Low Profile Tube define core use cases; Conventional Tube configurations include Balloon Retention Mechanism and Dome Retention Mechanism variants, each carrying implications for placement technique, maintenance protocols, and complication profiles, while Low Profile Tube options span Balloon Retention Mechanism and Water Inflated Retention formats that prioritize low visibility and patient comfort. End User segmentation highlights divergent operational and support needs across Ambulatory Surgical Center, Home Care, Hospitals, and Specialty Clinics; within Home Care the split between Professional Care and Self-Administered use cases dictates differing training programs and consumable bundling, and Hospitals subdivided into General Hospitals and Specialty Hospitals show variance in procurement scale and clinical procedure volume.

Distribution Channel dynamics encompass Direct Tender, Hospital Supply Chain, Online Sales, and Retail Pharmacy pathways; the Online Sales channel itself bifurcates into Manufacturer Website and Third-Party Platform routes, each requiring tailored service levels, documentation, and returns handling. Indication-driven segmentation for Cancer, Digestive Nutritional Disorder, Genetic Disorder, and Neurological Disorder identifies the clinical contexts that most frequently necessitate gastrostomy access and therefore shape device feature prioritization, such as feeding port ergonomics or anti-reflux design. Patient Age cohorts-Adult, Geriatric, and Pediatric-introduce age-specific considerations in tube diameter, securement strategies, and caregiver education requirements. Finally, Tube Material choices between Polyurethane and Silicone influence flexibility, patient tolerance, and long-term wear characteristics.

Taken together, these segmentation dimensions interact to create nuanced product-market fit scenarios. For example, low-profile, water-inflated retention systems often align with self-administered home care for pediatric and adult ambulatory patients who prioritize discreetness and ease of daily management, whereas conventional dome-retention configurations may remain preferred in high-volume hospital settings where rapid placement and established protocols dominate. Distribution channel selection further modulates service expectations; hospitals tend to prefer integrated supply agreements with robust clinical training, while online and retail channels necessitate clear consumer-facing instructions and accessible customer support. These layered insights inform targeted product development, tailored clinical support packages, and differentiated commercial strategies that respond to the distinct needs of each segmentation intersection.

How regional regulatory frameworks, care delivery models, and distribution infrastructures across Americas, EMEA, and Asia-Pacific shape clinical adoption and commercial strategy

Regional dynamics shape clinical practice patterns, regulatory priorities, and commercial channels for gastrostomy tube care across major geographic blocs. In the Americas, healthcare systems range from large integrated hospital networks to extensive home care ecosystems; this diversity drives strong demand for both institutional-grade conventional tubes and patient-friendly low-profile systems, with an emphasis on streamlined procurement processes and post-market clinical support. Clinical guidelines and payer frameworks in this region emphasize outcome tracking and cost-effectiveness, prompting stakeholders to align device selection with broader value-based care initiatives.

Europe, Middle East & Africa presents a complex mosaic of regulatory regimes and care delivery infrastructures, where national reimbursement policies and local clinical practice influence device adoption. Specialty hospitals and tertiary centers often lead in adopting novel retention mechanisms and materials, while home care expansion in select markets increases the importance of caregiver training and distributor partnerships. Manufacturers operating in this region benefit from robust clinical networks but must navigate varied reimbursement environments and localization requirements.

Asia-Pacific encompasses a rapidly evolving mix of developed and emerging healthcare systems with strong growth in ambulatory surgical centers and home-based care services. Local manufacturing capacity and regional regulatory harmonization efforts influence sourcing decisions, while consumer adoption of online channels supports expanded access to devices for home administration. Across all regions, differences in patient demographics, surgical practice patterns, and distribution infrastructure require region-specific go-to-market strategies and tailored evidence-generation priorities to support adoption and long-term device success.

Competitive and strategic company trends emphasizing clinical evidence, integrated service offerings, supply resilience, and digital engagement for sustainable advantage

Competitive dynamics in the gastrostomy tube space center on product differentiation, service integration, and evidence generation rather than mere price competition. Leading manufacturers and innovative challengers are investing in clinical studies that demonstrate reductions in device-related complications, improvements in quality of life, and simplified caregiver workflows. Strategic moves include portfolio expansion to cover both conventional and low-profile offerings, the creation of bundled service packages that combine device supply with clinician training and patient education, and partnerships with home health providers and specialty clinics to secure end-to-end care pathways.

Operational excellence is a critical source of competitive advantage; firms that optimize supply chain resilience, maintain rigorous quality systems, and offer rapid clinical support for procedural teams tend to secure stronger hospital relationships. At the same time, companies that develop compelling direct-to-consumer initiatives-comprehensive instructional content, easy re-order pathways, and responsive customer service-can capture share within home care and self-administered segments. Regulatory engagement and proactive post-market surveillance are also differentiators, as payers and procurement leaders increasingly demand robust safety data and transparent complaint handling.

Finally, acquisition and partnership activity continues to shape the landscape as manufacturers seek scale in distribution and complementary technologies. Investors and strategic buyers are attracted to firms that demonstrate a blend of clinical credibility, established institutional contracts, and scalable consumer-facing capabilities, underscoring the importance of integrated commercial models that bridge hospital procurement and home care adoption.

Actionable strategic priorities for manufacturers and healthcare leaders to improve product usability, evidence generation, distribution reach, and supply chain resilience

Industry leaders should prioritize a set of pragmatic actions to convert insight into measurable outcomes across clinical adoption, supply resilience, and commercial performance. First, align product development roadmaps with caregiver usability and home care requirements, investing in low-profile designs and retention mechanisms that reduce maintenance burden and improve patient comfort. Simultaneously, explore material innovations that maintain clinical performance while simplifying sterilization and production processes to support supply chain flexibility.

Second, strengthen omnichannel distribution capabilities by harmonizing documentation, training resources, and ordering workflows across direct tender, hospital supply, online manufacturer portals, third-party platforms, and retail pharmacy partners. This alignment reduces friction for both institutional purchasers and individual caregivers. Third, build rigorous clinical and economic evidence packages that address safety endpoints, complication reduction, and total cost of care. Tailored real-world studies and collaboration with specialty clinics can accelerate payer acceptance and institutional adoption.

Fourth, implement supply chain resilience measures such as multi-sourcing, strategic inventory buffering for critical components, and geographically diversified manufacturing to mitigate tariff and trade disruptions. Fifth, enhance post-market support through clinician education, caregiver training modules, and telehealth-enabled troubleshooting to improve patient adherence and reduce avoidable readmissions. Finally, pursue strategic partnerships with home health providers and specialty centers to create integrated care pathways that demonstrate improved outcomes and strengthen long-term procurement relationships.

Transparent multi-source research methodology combining clinician engagement, regulatory review, procurement practice analysis, and rigorous cross-validation of findings

Research methodology for this analysis combined structured primary engagement with domain experts, systematic review of peer-reviewed clinical literature, and triangulation of procurement and distribution practice patterns observed in healthcare delivery settings. Primary inputs included interviews with clinicians, supply chain managers, home health coordinators, and device engineers to capture operational nuances and real-world device performance considerations. Secondary inputs encompassed device labeling, regulatory filings, clinical registry publications, and procedural best-practice guidance to validate clinical and safety characteristics.

Analytical approaches integrated qualitative thematic synthesis with comparative assessment of device design attributes, retention mechanisms, and material properties to identify recurring performance differentiators. Distribution and commercial channel analysis drew on procurement documentation patterns and publicly disclosed tender frameworks to map typical contractual structures and service expectations. To ensure rigor, findings were cross-validated across stakeholder groups and reconciled against clinical literature and regulatory summaries.

Limitations include variable transparency of proprietary contract terms and heterogeneity in regional clinical practice that may influence local adoption dynamics. Where possible, the methodology explicitly notes contextual dependencies and suggests follow-up primary research to address market-specific questions. The approach emphasizes reproducibility and clarity, enabling stakeholders to adapt the framework to their internal datasets and decision-making processes.

Concise synthesis of the device, clinical, commercial, and operational imperatives that will determine long-term adoption and value creation in gastrostomy care

In summary, the gastrostomy tube landscape is being reshaped by intersecting forces: product innovation aimed at patient comfort and ease of home management, shifting care delivery models that emphasize ambulatory and home-based services, distribution diversification across institutional and consumer channels, and macroeconomic pressures that prompt supply chain reconfiguration. These dynamics collectively require manufacturers, providers, and procurement teams to adopt integrated strategies that consider device design, evidence generation, service delivery, and operational resilience as interdependent priorities.

Sustained success will depend on the ability to deliver clinically robust devices that are supported by comprehensive training, rapid post-market responsiveness, and distribution models that meet the distinct expectations of hospitals, home care providers, and individual caregivers. By focusing on value-based outcomes, strengthening supplier and manufacturing flexibility, and investing in consumer-oriented support mechanisms, stakeholders can improve patient experience while navigating regulatory and commercial complexity. The collective emphasis on safety, simplicity, and support forms the foundation for long-term adoption and clinical benefit.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Gastrostomy Tube Market, by Tube Material

  • 8.1. Polyurethane
  • 8.2. Silicone

9. Medical Gastrostomy Tube Market, by Indication

  • 9.1. Cancer
  • 9.2. Digestive Nutritional Disorder
  • 9.3. Genetic Disorder
  • 9.4. Neurological Disorder

10. Medical Gastrostomy Tube Market, by Patient Age

  • 10.1. Adult
  • 10.2. Geriatric
  • 10.3. Pediatric

11. Medical Gastrostomy Tube Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Home Care
    • 11.2.1. Professional Care
    • 11.2.2. Self-Administered
  • 11.3. Hospitals
    • 11.3.1. General Hospitals
    • 11.3.2. Specialty Hospitals
  • 11.4. Specialty Clinics

12. Medical Gastrostomy Tube Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online
    • 12.2.1. Manufacturer Website
    • 12.2.2. eCommerce Platform

13. Medical Gastrostomy Tube Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Gastrostomy Tube Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Gastrostomy Tube Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Gastrostomy Tube Market

17. China Medical Gastrostomy Tube Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Applied Medical Technology, Inc.
  • 18.6. Avanos Medical, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. Cardinal Health, Inc.
  • 18.10. ConMed Corporation
  • 18.11. Cook Medical LLC
  • 18.12. Danone S.A.
  • 18.13. Degania Medical Devices Ltd.
  • 18.14. Fresenius SE & Co. KGaA
  • 18.15. Global Medikit Limited
  • 18.16. GST Corporation Limited
  • 18.17. Halyard Health, Inc.
  • 18.18. Integra LifeSciences Holdings Corporation
  • 18.19. Medicina Ltd.
  • 18.20. Medtronic plc
  • 18.21. Poly Medicure Limited
  • 18.22. Romsons International
  • 18.23. Teleflex Incorporated
  • 18.24. Vygon S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DIGESTIVE NUTRITIONAL DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENETIC DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY NEUROLOGICAL DISORDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PROFESSIONAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SELF-ADMINISTERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ECOMMERCE PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 163. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GCC MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. G7 MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 192. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 195. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 199. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. NATO MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY TUBE MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY PATIENT AGE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA MEDICAL GASTROSTOMY TUBE MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)